ARTL
$2.06
Artelo Biosciences
($.08)
(3.74%)
ARTL
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Nov 25
6:05 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when ARTL reports earnings?
Beat
Meet
Miss

Where is ARTL's stock price going from here?
Up
Flat
Down
Stock chart of ARTL
Analysts
Summary of analysts' recommendations for ARTL
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Aristotle Corporation is a holding company which, through its wholly-owned subsidiary, Simulaids, Inc., manufactures health and medical education teaching aids. The company's primary products include manikins, and simulation kits used for training in CPR, emergency rescue and patient care fields. The products are sold throughout the United States and internationally via distributors and catalogs to end users such as fire and emergency medical departments and nursing and medical schools.